Clin2
NCT05469854Worth exploringRecruiting

Study of linaprazan glurate in healthy volunteers

PharmacokineticsCardiodynamic ECGSafety, and TolerabilityGERD

Treatments studied

Part of Digestive system clinical trials.

This study tests a new drug called linaprazan glurate in healthy adults aged 18 to 65. It looks at how the drug moves through your body and if it affects your heart rhythm.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
121 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are in good general health (no major medical conditions).
  • Your body mass index (BMI) is between 18.5 and 35.0.
  • You and your partner must use effective birth control during the study.
  • You do not have a history of acid reflux or GERD.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07277712Not yet recruiting· Phase 1
Study of a new tablet for healthy adults

This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.

Jeonju
NCT07678177Recruiting
Study of tegoprazan for patients with GERD

This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.

Seoul
NCT07752407Recruiting· Phase 3
Heartburn relief study for people with non-erosive GERD

This study tests a new medicine called vonoprazan to see if it can reduce episodes of heartburn in people who have GERD but no damage to their esophagus. It compares the medicine to a placebo (a pill with no active ingredient) over 24 weeks.

Mentor, Ohio
NCT07010107Recruiting· Phase 3
Testing anaprazole for moderate to severe reflux esophagitis

This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.

Shanghai, Shanghai Municipality
NCT06284876Recruiting· Phase 3
Testing Ilaprazole for Preventing NSAID-Related Stomach Ulcers

This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.

Seoul
NCT07727629Not yet recruiting· Phase 1
Comparing two study drugs in healthy volunteers

This trial tests two similar study drugs to see how they compare in terms of safety and how the body processes them. It is for healthy adults who want to help with early-stage medication research.

Cheongju-si, North Chungcheong

Hear when a new Pharmacokinetics trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.